Characterization of Biophysical and Metabolic Properties of Cells Labeled with Superparamagnetic Iron Oxide Nanoparticles and Transfection Agent for Cellular MR Imaging

Radiology

Volumn 229, Issue 3, 2003, Pages 838-846

  Arbab, Ali S ^a   Bashaw, Lindsey A ^a   Miller, Bradley R ^a   Jordan, Elaine K ^a   Lewis, Bobbi K ^a   Kalish, Heather ^a   Frank, Joseph A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cell labeling; Contrast media, experimental studies; Experimental study; Iron; Magnetic resonance (MR), contrast media; Radiobiology, cell and tissue studies

Indexed keywords

FERRIC FERROCYANIDE; IRON; NANOPARTICLE; POLYLYSINE; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL FUNCTION; CELL GROWTH; CELL LABELING; CELL LEVEL; CELL LINE; CELL LINEAGE; CELL METABOLISM; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DATA ANALYSIS; ELECTRICITY; ENDOSOME; EVALUATION; GROWTH RATE; HELA CELL; HUMAN; HUMAN CELL; INCUBATION TIME; IRON TRANSPORT; LIFESPAN; MAGNETISM; MAMMAL CELL; MESENCHYME CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STAINING; STEM CELL; STUDENT T TEST;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CONTRAST MEDIA; FERROCYANIDES; HELA CELLS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; OXIDES; PARTICLE SIZE; POLYLYSINE; REACTIVE OXYGEN SPECIES; STEM CELLS;

EID: 0344633614     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2293021215     Document Type: Article

References (22)

1. Fukuchi K, Tomoyasu S, Tsuruoka N, Gomi K. Iron deprivation-induced apoptosis in HL-60 cells. FEBS Lett 1994; 350:139-142.
2. Porreca E, Ucchino S, Di Febbo C, et al. Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arterioscler Thromb 1994; 14:299-304.
3. Gutteridge JM, Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radical and lipid peroxidation in the presence of iron salt: detection of catalytic iron and antioxidant activity in extracellular fluids. Biochem J 1982; 206:605-609.
4. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 2001; 55:333-339.
5. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol 1990; 155:943-950.
6. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn Reson Imaging 1991; 9:275-283.
7. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152:167-173.
8. Bulte JWM, Douglas T, Witwer B, et al. Magnetodedrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 2001; 19:1141-1147.
9. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-tat peptide conjugates. Bioconjug Chem 1999; 10:186-191.
10. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18:410-414.
11. Thomson JA, Itskovitx-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282:1145-1147.
12. Shamblott MJ, Axelman J, Wang S, et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci USA 1998; 95:13726-13731.
13. McKay R. Stem cells: hype and hope. Nature 2000; 406:361-364.
14. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-147.
15. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28:875-884.
16. Bulte JMW, Zhang SC, van Gelderen P, et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci USA 1999; 96:15256-15261.
17. Frank JA, Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol 2002; 9(suppl 2):S484-S487.
18. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian cells and stem cells by combining superparamagnetic iron oxides and commonly available transfection agents. Radiology 2003; 228:480-487.
19. Heohn M, Küstermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 2002; 99:16267-16272.
20. Skotland T, Sontum PC, Oulie I. In vitro stability analysis as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. J Pharm Biomed Anal 2002; 28:323-329.
21. Rausch M, Sauter A, Fröhlich J, Neubacher U, Radü EW, Rudin M. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage. Magn Reson Med 2001; 46:1018-1022.
22. Rausch M, Baumann D, Neubacher U, Rudin M. In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 2002; 15:278-283.